# AusperBio Reports Sustained Functional Cure up to 15 Months Off All HBV Treatment in Treatment-Naïve and NA-Treated Patients with Chronic Hepatitis B

- Source: PR Newswire M&A
- Published: 2026-11-06T00:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/ausperbio-reports-sustained-functional-cure-up-to-15-months-off-all-hbv-treatment-in-treatment-naive-and-na-treated-patients-with-chronic-hepatitis-b-302931475.html
- Canonical: https://groundlevelnews.com/story/ausperbio-reports-sustained-functional-cure-up-to-15-months-off-all-hb-1e30bc/

Long-term follow-up supports AHB-137 as a potential finite-duration therapy; data featured in two late-breaking oral presentations at AASLD The Liver Meeting® 2026 Key Findings NA-treated participants: Functional cure was maintained in 16 of 17 evaluable participants at 12 months and 9 of...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._